Renal Cell Carcinoma by Nizar M. TannirRenal Cell Carcinoma by Nizar M. Tannir

Renal Cell Carcinoma

EditorNizar M. Tannir

Paperback | November 19, 2014

Pricing and Purchase Info


Earn 265 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


While patients with metastatic renal cell carcinoma (mRCC) are now living longer with improved quality of life, the success of novel therapies for mRCC has created challenges for practicing oncologists. Many patients who initially respond to targeted therapies ultimately develop progressivedisease due to acquired resistance to these agents. Additionally, some patients do not respond at all to any of the currently approved targeted agents, underscoring the need for continued and concerted efforts to identify other relevant targets and pursue alternative therapeutic strategies. Part of the Oxford American Oncology Library, Renal Cell Carcinoma is a concise handbook that addresses the complex management of patients with mRCC. The book begins with a review of the epidemiology, pathology, and biology of renal cell carcinoma followed by chapters on specific targeted therapiesand managing complications. The final chapters discuss supportive and integrative care and emerging therapies.
Nizar M. Tannir is Associate Professor, and Deputy Department Chair, Department of Genitourinary Medical Oncology, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center, Houston, Texas.
Title:Renal Cell CarcinomaFormat:PaperbackDimensions:192 pages, 8 × 5 × 0.68 inPublished:November 19, 2014Publisher:Oxford University PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0199988137

ISBN - 13:9780199988136

Look for similar items by category:


Table of Contents

1. Epidemiology of Renal Cell Carcinoma2. Pathology of Renal Cell Carcinoma3. Biology of Renal Cell Carcinoma4. Inherited Renal Cell Cancers5. Interventional Radiology Procedures in Renal Cell Carcinoma6. Management of Small Renal Masses and Early-Stage Renal Cell Carcinoma7. Staging and Surgical Management of Locally Advanced Renal Cell Carcinoma and the Role of Adjuvant and Neoadjuvant Therapy8. Integration of Targeted Therapy with Cytoreductive Nephrectomy and Metastasectomy in the Management of Metastatic Renal Cell Carcinoma9. Immunotherapeutic Approaches for Metastatic Conventional-Type Renal Cell Carcinoma10. Targeted Therapies for Metastatic Conventional-Type Renal Cell Carcinoma11. Systemic Therapies for Metastatic Renal Cell Carcinoma of Variant Histology12. Prognostic and Predictive Biomarkers in Renal Cell Carcinoma13. Management of Complications of Targeted Therapies for Metastatic Renal Cell Carcinoma14. The Role of Traditional and Stereotactic Radiation in Metastatic Renal Cell Carcinoma15. Supportive Care in Advanced Renal Cell Carcinoma16. Integrative Medicine in the Management of Renal Cell Carcinoma17. Emerging Therapies and Future Directions in Renal Cell Carcinoma